Graves' orbitopathy results in profound changes in tear composition: A study of plasminogen activator inhibitor-1 and seven cytokines

Thyroid

Volumn 22, Issue 4, 2012, Pages 407-414

  Ujhelyi, Bernadett ^a   Gogolak, Peter ^a   Erdei, Annamaria ^a   Nagy, Valeria ^a   Balazs, Erzsebet ^a   Rajnavolgyi, Eva ^a   Berta, Andras ^a   Nagy, Endre V ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ACTIVITY SCORE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; ENDOCRINE OPHTHALMOPATHY; EYE EXAMINATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RATING SCALE; T LYMPHOCYTE; TEAR FILM;

ADULT; ALGORITHMS; ANALYSIS OF VARIANCE; CHEMOKINE CCL5; CHEMOKINES; CYTOKINES; EYE; FEMALE; FUNCTIONAL LATERALITY; GRAVES DISEASE; GRAVES OPHTHALMOPATHY; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; SMOKING; SOFTWARE; TEARS;

EID: 84859356955     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0248     Document Type: Article

References (53)

1. Burch HB, Wartofsky L 1993 Graves ophthalmopathy- current concepts regarding pathogenesis and management. Endocr Rev 14:747-793. (Pubitemid 24016660)
2. Marcocci C, Bartalena L, Bogazzi F, Panicucci M, Pinchera A 1989 Studies on the occurence of ophthalmopathy in Gravesdisease. Acta Endocrinol 120:473-478.
3. Solomon DH, Chopra IJ, Chopra U, Smith FJ 1977 Identification of subgroups of euthyroid Graves ophthalmopathy. N Engl J Med 296:181-186. (Pubitemid 8031204)
4. Weetman AP, Cohen S, Gatter KC, Fells P, Shine B 1989 Immunohistochemical analysis of the retrobulbar tissues in Graves ophthalmopathy. Clin Exp Immunol 75:222-227. (Pubitemid 19074250)
5. Natt N, Bahn RS 1997 Cytokines in the evolution of Graves' ophthalmopathy. Autoimmunity 26:129-136. (Pubitemid 27499612)
6. Kumar S, Bahn RS 2003 Relative overexpression of macrophage- derived cytokines in orbital adipose tissue from patients with Graves' ophthalmopathy. J Clin Endocrinol Metab 88:4246-4250. (Pubitemid 37153727)
7. Wakelkamp I, Gerding MN, Van Der Meer JWC, Prummel MF, Wiersinga WM 2000 Both Th1-and Th2-derived cytokines in serum are elevated in Graves' ophthalmopathy. Clin Exp Immunol 121:453-457.
8. Salvi M, Pedrazzoni M, Girasole G, Giuliani N, Minelli R, Wall JR, Roti E 2000 Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. Eur J Endocrinol 143:197-202. (Pubitemid 30622353)
9. Cawood TJ, Moriarty P, O'Farrelly C, O'Shea D 2006 The effects of tumour necrosis factor-alpha and interleukin1 on an in vitro model of thyroid-associated ophthalmopathy; contrasting effects on adipogenesis. Eur J Endocrinol 155: 395-403. (Pubitemid 44463945)
10. Gianoukakis AG, Khadavi N, Smith TJ 2008 Cytokines, Graves' disease, and thyroid-associated ophthalmopathy. Thyroid 18:953-958.
11. Xia N, Zhou SX, Liang YZ, Xiao CQ, Shen HL, Pan HL, Deng HM, Wang NZ, Li QDQ 2006 CD4( +) T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy. Int J Mol Med 17:911-916.
12. Wiersinga WM, Bartalena L 2002 Epidemiology and prevention of Graves' ophthalmopathy. Thyroid 12:855-860. (Pubitemid 35332989)
13. Mourits MP, Prummel MF, WiersingaWM, Koornneef L 1997 Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol 47: 9-14. (Pubitemid 27313981)
14. Uchino E, Sonoda S, Kinukawa N, Sakamoto T 2006 Alteration pattern of tear cytokines during the course of a day: diurnal rhythm analyzed by multicytokine assay. Cytokine 33:36-40. (Pubitemid 43220350)
15. Uchino E, Sonoda S, Nakao K, Sakamoto T 2006 Alteration of tear cytokine balance by eye closure: analysis by multicytokine assay. Graefes Arch Clin Exp Ophthalmol 244: 747-749. (Pubitemid 43923198)
16. Fodor M, Facsko A, Rajnavolgyi E, Harsfalvi J, Bessenyei E, Kardos L, Berta A 2006 Enhanced release of IL-6 and IL-8 into tears in various anterior segment eye diseases. Ophthalmic Res 38:182-188. (Pubitemid 44213977)
17. Leonardi A, Curnow SJ, Zhan H, Calder VL 2006 Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. Clin Exp Allergy 36:777-784. (Pubitemid 43972973)
18. Mrugacz M, Kaczmarski M, Bakunowicz-Lazarczyk A, Zelazowska B, Wysocka J, Minarowska A 2006 IL-8 and IFN-gamma in tear fluid of patients with cystic fibrosis. J Interferon Cytokine Res 26:71-75. (Pubitemid 43364043)
19. Malvitte L, Montange T, Vejux A, Baudouin C, Bron AM, Creuzot-Garcher C, Lizard G 2007 Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs. Br J Ophthalmol 91:29-32. (Pubitemid 46094003)
20. Pflugfelder SC, Jones D, Ji ZH, Afonso A, Monroy D 1999 Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren's syndrome keratoconjunctivitis sicca. Curr Eye Res 19:201-211. (Pubitemid 29500267)
21. Yoon KC, Jeong IY, Park YG, Yang SY 2007 Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. Cornea 26:431-437.
22. Rummenie VT, Matsumoto Y, Dogru M, Wang Y, Hu YQ, Ward SK, Igarashi A, Wakamatsu T, Ibrahim O, Goto E, Luyten G, Inoue H, Saito I, Shimazaki J, Tsubota K 2008 Tear cytokine and ocular surface alterations following brief passive cigarette smoke exposure. Cytokine 43: 200-208.
23. Baker GRC, Morton M, Rajapaska RS, Bullock M, Gullu S, Mazzi B, Ludgate M 2006 Altered tear composition in smokers and patients with Graves ophthalmopathy. Arch Ophthalmol 124:1451-1456. (Pubitemid 44537146)
24. Gilbard JP, Farris RL 1983 Ocular surface drying and tear film osmolarity in thyroid eye disease. Acta Ophthalmol 61:108-116. (Pubitemid 13194550)
25. Khurana AK, Sunder S, Ahluwalia BK, Malhotra KC 1992 Tear film profile in Graves ophthalmopathy. Acta Ophthalmol 70:346-349.
26. Khalil HA, Dekeizer RJW, Kijlstra A 1988 Analysis of tear proteins in Graves ophthalmopathy by highperformance liquid-chromatography. Am J Ophthalmol 106:186-190.
27. Chang TC, Huang KM, Chang TJ, Lin SL 1990 Correlation of orbital computed-tomography amd antibodies in patients with hyperthyroid Graves-disease. Clin Endocrinol 32:551-558. (Pubitemid 20151450)
28. Eckstein AK, Finkenrath A, Heiligenhaus A, Renzing-Kohler K, Esser J, Kruger C, Quadbeck B, Steuhl KP, Gieseler RK 2004 Dry eye syndrome in thyroid-associated ophthalmopathy: lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodies. Acta Ophthalmol Scand 82: 291-297. (Pubitemid 38714645)
29. Dias AC, Modulo CM, Jorge AG, Braz AM, Jordao AA, Bertazolli R, de Paula JS, Rocha EM 2007 Influence of thyroid hormone on thyroid hormone receptor beta-1 expression and lacrimal gland and ocular surface morphology. Invest Ophthalmol Vis Sci 48:3038-3042. (Pubitemid 351261145)
30. Moncayo R, Baldissera I, Decristoforo C, Kendler D, Donnemiller E 1997 Evaluation of immunological mechanisms mediating thyroid-associated ophthalmopathy by radionuclide imaging using the somatostatin analog In-111-octreotide. Thyroid 7:21-29. (Pubitemid 27132891)
31. Kainz H, Bale R, Donnemiller E, Gabriel M, Kovacs P, Decristoforo C, Moncayo R 2003 Image fusion analysis of Tc-99m-HYNIC-octreotide scintigraphy and CT/MRI in patients with thyroid-associated orbitopathy: The importance of the lacrimal gland. Eur J Nucl Med Mol Imaging 30:1155-1159. (Pubitemid 36988227)
32. Cavusoglu T, Nurozler AB, Titiz C, Ustun H, Aral Y, Ozer E, Kasim R, Tezel S 2007 Tear function and ocular surface changes in multinodular goiter patients. Ophthalmologica 221:264-268. (Pubitemid 46956805)
33. Okrojek R, Grus FH, Matheis N, Kahaly GJ 2009 Proteomics in autoimmune thyroid eye disease. Horm Metab Res 41:465-470.
34. Anvari M, Khalilzadeh O, Esteghamati A, Esfahani SA, Rashidi A, Etemadi A, Mahmoudi M, Amirzargar AA 2010 Genetic susceptibility to Graves' ophthalmopathy: The role of polymorphisms in proinflammatory cytokine genes. Eye 24:1058-1063.
35. Liu YH, Chen RH, Wu HH, Liao WL, Chen WC, Tsai YH, Tsai CH, Wan L, Tsai FJ 2010 Association of interleukin-1 beta (IL1B) polymorphisms with Graves' ophthalmopathy in Taiwan Chinese patients. Invest Ophthalmol Vis Sci 51: 6238-6246.
36. Fay WP 2004 Plasminogen activator inhibitor 1, fibrin, and the vascular response to injury. Trends Cardiovas Med 14: 196-202. (Pubitemid 38942828)
37. Gils A, Declerck PJ 2004 Plasminogen activator inhibitor-1. Curr Med Chem 11:2323-2334. (Pubitemid 39172352)
38. Hou BD, Eren M, Painter CA, Covington JW, Dixon JD, Schoenhard JA, Vaughan DE 2004 Tumor necrosis factor alpha activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor kappa B site. J Biol Chem 279:18127-18136. (Pubitemid 38623225)
39. Wahrenberg H, Wennlund A, Hoffstedt J 2002 Increased adipose tissue secretion of interleukin-6, but not of leptin, plasminogen activator inhibitor-1 or tumour necrosis factor alpha, in Graves' hyperthyroidism. Eur J Endocrinol 146:607-611. (Pubitemid 34552492)
40. Wiersinga WM, Perros P, Kahaly GJ, Mourits MP, Baldeschi L, Boboridis K, Boschi A, Dickinson AJ, Kendall-Taylor P, Krassas GE, Lane CM, Lazarus JH, Marcocci C, Marino M, Nardi M, Neoh C, Orgiazzi J, Pinchera A, Pitz S, Prummel MF, Sartini MS, Stahl M, von Arx G, European Group Graves Orbitopathy EU 2006 Clinical assessment of patients with Graves' orbitopathy: The European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol 155:387-389. (Pubitemid 44463943)
41. Paschides CA, Kitsios G, Karakostas KX, Psillas C, Moutsopoulos HM 1989 Evaluation of tear break-up time, Schirmers-I test and Rose-Bengal staining as confirmatory tests for keratoconjunctivitis sicca. Clin Exp Rheumatol 7:155-157. (Pubitemid 19136951)
42. Feldmann M, Brennan FM, Chantry D, Haworth C, Turner M, Katsikis P, Londei M, Abney E, Buchan G, Barrett K, Corcoran A, Kissonerghis M, Zheng R, Grubeckloebenstein B, Barkley D, Chu CQ, Field M, Maini RN 1991 Cytokine assays-role in evaluation of the pathogenesis of autoimmunity. Immunol Rev 119:105-123.
43. Salvi M, Girasole G, Pedrazzoni M, Passeri M, Giuliani N, Minelli R, Braverman LE, Roti E 1996 Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease. J Clin Endocrinol Metab 81:2976-2979. (Pubitemid 26323895)
44. Carreno E, Enriquez-de-Salamanca A, Teson M, Garcia- Vazquez C, Stern ME, Whitcup SM, Calonge M 2010 Cytokine and chemokine levels in tears from healthy subjects. Acta Ophthalmol 88:e250-e258.
45. Versura P, Campos EC 2010 The ocular surface in thyroid diseases. Curr Opin Allergy Clin Immunol 10:486-492.
46. Gupta A, Sadeghi PB, Akpek EK 2009 Occult thyroid eye disease in patients presenting with dry eye symptoms. Am J Ophthalmol 147:919-923.
47. Mysliwiec J, Kretowski A, Stepien A, Mironczuk K, Kinalska I 2003 Interleukin 18 and transforming growth factor beta 1 in the serum of patients with Graves' ophthalmopathy treated with corticosteroids. Int Immunopharmacol 3:549-552. (Pubitemid 36419515)
48. Lam H, Bleiden L, De Paiva CS, Farley W, Stern ME, Pflugfelder SC 2009 Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol 147:198-205.
49. Gurdal C, Sarac O, Genc I, Kirimlioglu H, Takmaz T, Can I 2011 Ocular surface and dry eye in Graves' disease. Curr Eye Res 36:8-13.
50. Cook EB 2004 Tear cytokines in acute and chronic ocular allergic inflammation. Curr Opin Allergy Clin Immunol 4:441-445. (Pubitemid 39274088)
51. Yamada T, Sato A, Komiya I, Nishimori T, Ito Y, Terao A, Eto S, Tanaka Y 2000 An elevation of serum immunoglob- ulin E provides a new aspect of hyperthyroid Graves' disease. J Clin Endocrinol Metab 85:2775-2778. (Pubitemid 32269150)
52. Enzmann DR, Donaldson SS, Kriss JP 1979 Appearance of Graves-disease on orbital computed-tomography. J Comput Assist Tomogr 3:815-819.
53. Wang ZY, Sosne G, Kurpakus-Wheater M 2005 Plasminogen activator inhibitor-1 (PAI-1) stimulates human corneal epithelial cell adhesion and migration in vitro. Exp Eye Res 80:1-8. (Pubitemid 40126508)